Cost-effectiveness of a 21-gene recurrence score assay versus Canadian clinical practice in women with early-stage estrogen- or progesterone-receptor-positive, axillary lymph-node negative breast cancer

✍ Scribed by Malek B Hannouf, Bin Xie, Muriel Brackstone, Gregory S Zaric

• Book ID: 119897489
• Publisher: BioMed Central
• Year: 2012
• Tongue: English
• Weight: 314 KB
• Volume: 12
• Category: Article
• ISSN: 1471-2407
• DOI: 10.1186/1471-2407-12-447